Diabetic diarrhoea is a common complication of insulin dependent diabetes mellitus.' High volume watery diarrhoea in diabetics may be chronic and refractory to conventional antidiarrhoeal treatments. The mechanisms involved are complex and often multifactorial. In diabetics with severe autonomic neuropathy in whom small intestinal and pancreatic disease has been excluded and bacterial overgrowth ruled out, neurological damage directly or indirectly to the enteric nervous system is thought to be an important factor.2 The enteric nervous system is not only important for controlling intestinal motility but also for modulating intestinal secretory and absorptive processes. The somatostatin analogue, octreotide, has been found to be effective in the treatment of chronic refractory diarrhoea caused by AIDS enteropathy,3 short bowel syndrome4 and idiopathic secretory diarrhoea. 5 The most obvious abnormalities detected were rapid small and whole gut transit times. Mouth to caecum transit time measured by lactulose hydrogen breath test using a standard meal with 40 ml lactulose was short at 45 minutes (normal range 87 (7)) and total gut transit time estimated by the radioopaque marker technique9 was nine hours (normal range 24-48 hours). A prolonged (17 hour) small intestinal manometric study revealed migrating motor complexes with normal periodicity. The phase III activity fronts propagated rapidly with a mean velocity of 15 cm/minute (normal 5 (2-3), n=10) in the proximal jejunum, and 7.5 cm/min (normal 3-4 (1-9), n= 10) in the distal jejunum. The contractile frequency within the phase III front was increased at 13 contractions per minute (normal 11.5 (1-9)) in the proximal jejunum and 12 contractions per minute (normal 10-3 (0-3)) in the distal jejunum. Water absorption from 30 cm segment of jejunum perfused with a plasma electrolyte solution (Na 140, K 4, Cl 140, HCO3 40 mmol/l) using a triple lumen catheter'0 was normal (2 ml/cm/h; normal 1-4) and increased appropriately with the addition of glucose (90 mmol/l) and glucose polymer (18 mmol/l) ( In general, the treatment of diabetic diarrhoea has proved so far to be unrewarding, and many therapeutic trials using known antidiarrhoeal agents have failed to improve the incapacitating diarrhoea in these patients. Despite the rapid transit time in our patient, she failed to respond to drugs such as codeine phosphate and loperamide that slow intestinal motility. Because of the loss of intestinal adrenergic innervation in diabetic patients, clonidine and lidamidine which are alpha 2 adrenergic agonists have been found to be beneficial in the treatment ofdiabetic diarrhoea probably by stimulating the alpha 2 adrenergic receptors on enterocytes." 12 Our patient, however, failed to respond to clonidine. Octreotide has been previously reported to be beneficial in the treatment of other refractory diarrhoeas including AIDS enteropathy, short bowel syndrome and idiopathic refractory diarrhoea. Animal and human studies suggest that it acts by enhancing water and sodium absorption from the small intestine,'3 by inhibiting chloride secretion in the colon'4 and by prolonging mouth to caecum transit time.'' Its mode of action in diabetic diarrhoea, however, has not been extensively studied. Octreotide reduced stool weight and frequency in our patient, and the stools became well formed. In addition, she had a remarkable subjective improvement and for the first time in two years she was able to conduct a normal life socially and professionally. Although the total gut transit time did not change, octreotide prolonged mouth to caecum transit time almost five-fold, presumably allowing greater small intestinal water absorption. The 
